Healthcare Industry News:  joint replacement 

Devices Orthopaedic Neurology Distribution

 News Release - July 31, 2006

Collagen Matrix Signs Agreement with Stryker Orthopaedics for Distribution of Neuroflex(TM) and NeuroMatrix(TM) Collagen Nerve Cuff Products

FRANKLIN LAKES, N.J., July 31 (HSMN NewsFeed) -- Collagen Matrix, Inc. announced today that it has signed an agreement with Stryker Orthopaedics for the exclusive worldwide (except Canada) distribution of its Neuroflex(TM) Flexible Collagen Nerve Cuff and NeuroMatrix(TM) Collagen Nerve Cuff. Since January of 2005, Neuroflex and NeuroMatrix have been marketed by Collagen Matrix and sold through a network of independent agents and distributors in the U.S. and Europe. Effective immediately, Collagen Matrix will begin transitioning the distribution of Neuroflex and NeuroMatrix to the Stryker Orthopaedics sales and marketing team. In order to maintain consistency and provide for a smooth transition for our customers, the product will continue to carry the Neuroflex and NeuroMatrix trade names owned by Collagen Matrix.

Neuroflex and NeuroMatrix are safe, resorbable, collagen-based tubular matrices intended for use in the repair of severed peripheral nerves. As a design improvement to the NeuroMatrix straight collagen nerve guides, Neuroflex has a unique kink-resistant property that allows the nerve guide to bend without kinking or collapsing. Both products are implanted using an efficient entubulation technique. The tubular nerve guide bridges the severed nerve and provides a protective environment to guide the regeneration of the nerve across the gap.

"As we continue our collaboration with affiliates of Stryker Corporation with the successful completion of our second marketing and distribution agreement, we are confident that Stryker Orthopaedics' highly-skilled and focused sales and marketing teams will significantly increase the presence of our innovative collagen-based products in the field," said Shu-Tung Li, Ph.D., Founder and CEO of Collagen Matrix.

Stryker Corporation is one of the world's leading medical technology companies with a broad based range of products in orthopaedics and a significant presence in other medical specialties. Stryker works with respected medical professionals to help people lead more active and more satisfying lives. The company's products include implants used in joint replacement, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment. Stryker also provides outpatient physical therapy services in the United States. The company's website address is http://www.stryker.com.

Collagen Matrix, Inc. is a leader in the design and engineering of collagen-based extracellular matrices for tissue and organ repair and regeneration. Since its inception in 1997, the Company has received many government grants for the development of collagen-based matrix products in the areas of neurological, vascular, urological, and orthopedic tissue regeneration applications. The Company currently manufactures collagen-based finished medical devices in the areas of neurosurgery, oral surgery, orthopedic-spine surgery, and wound care. More information about the Company can be found at www.collagenmatrix.com.


Source: Collagen Matrix

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.